Recent News

• 09.10.2025 - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
• 06.20.2025 - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry
• 05.06.2025 - University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
• 04.25.2025 - ARS - Annual Report to Security Holders
• 03.18.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.06.2025 - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry

Recent Filings

• 09.10.2025 - 8-K Current report
• 09.10.2025 - EX-99.1 EX-99.1
• 08.18.2025 - 8-K Current report
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.14.2025 - 8-K Current report
• 06.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2025 - 8-K Current report
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - ARS Annual Report to Security Holders